Controversies Surrounding Alzheimer's Drug Treatments

Exploring the safety and efficacy of new Alzheimer's drug treatments, including the case of Annualhelm and the controversy surrounding FDA approval based on surrogate markers rather than clinical benefits, leading to criticism and resignations among committee members.